Last update 20 Mar 2025

Recombinant erythropoietin(University of Chile)

Overview

Basic Info

Drug Type
Colony-stimulating factors
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Hemic and Lymphatic DiseasesUrogenital Diseases
Active Indication
AnemiaChronic Kidney Diseases
Inactive Indication-
Originator Organization
University of ChileUniversity of Chile
Active Organization
University of ChileUniversity of Chile
Inactive Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

2
Clinical Trials associated with Recombinant erythropoietin(University of Chile)
IRCT20211202053252N1
/ RecruitingPhase 3IIT
Comparison of recombinant erythropoietin effect on serum hemoglobin of beta thalassemia minor versus non-thalassemia patients in chemotherapy candidates
IRCT20200509047364N1
/ RecruitingPhase 2IIT
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients
100 Clinical Results associated with Recombinant erythropoietin(University of Chile)
Login to view more data
100 Translational Medicine associated with Recombinant erythropoietin(University of Chile)
Login to view more data
100 Patents (Medical) associated with Recombinant erythropoietin(University of Chile)
Login to view more data
4
Literatures (Medical) associated with Recombinant erythropoietin(University of Chile)
01 Jan 1988Society of General Physiologists series
The role of purified and recombinant hematopoietic growth factors in the regulation of various stages of human megakaryocytopoiesis.
01 Jan 1986Progress in clinical and biological research
Megakaryocyte colony stimulating activity of recombinant human and monkey erythropoietin.
Acta Médica Portuguesa
Anemia da Doença Renal Crónica: O Estado da Arte
100 Deals associated with Recombinant erythropoietin(University of Chile)
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ASCO2008
Not Applicable
-
-
dfifnzghwo(rrzzvlkmtj) = vezypvlnyy cjcmwljamj (hjowntqaxa )
View more
-
20 May 2008
dfifnzghwo(rrzzvlkmtj) = cgrwflrdvu cjcmwljamj (hjowntqaxa )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free